ASC-话题@MedSci

#ASC#

1352篇内容 | 3936人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1939060, encodeId=288a19390603d, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2020：3年或1年伊马替尼辅助治疗高危胃肠道间质瘤的10年随访结果, objectType=article, longId=194649, objectId=61e919464970, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61e919464970, replyNumber=0, likeNumber=68, createdTime=2020-09-21, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61e919464970, moduleTitle=ASCO 2020：3年或1年伊马替尼辅助治疗高危胃肠道间质瘤的10年随访结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61e919464970)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939049, encodeId=f8aa193904928, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=J Cardiovasc Pharmacol Ther：烟民心梗应用氯吡格雷和他汀获益大！高润霖院士等发表CPACS-3研究, objectType=article, longId=193428, objectId=0ecb1934282c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ecb1934282c, replyNumber=0, likeNumber=68, createdTime=2021-03-12, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ecb1934282c, moduleTitle=J Cardiovasc Pharmacol Ther：烟民心梗应用氯吡格雷和他汀获益大！高润霖院士等发表CPACS-3研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ecb1934282c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939034, encodeId=862a1939034f7, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=BMC Cardiovasc Disord：非甲状腺疾病综合征和肾功能不全的合并进一步增加了急性心肌梗死患者的死亡风险, objectType=article, longId=189232, objectId=b5b3189232d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5b3189232d4, replyNumber=0, likeNumber=64, createdTime=2020-07-24, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5b3189232d4, moduleTitle=BMC Cardiovasc Disord：非甲状腺疾病综合征和肾功能不全的合并进一步增加了急性心肌梗死患者的死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5b3189232d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939113, encodeId=99d61939113d8, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=J Vasc Surg ：近端支架联合或不联合远端裸支架治疗主动脉夹层荟萃分析, objectType=article, longId=202666, objectId=61cd20266659, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61cd20266659, replyNumber=0, likeNumber=78, createdTime=2020-11-20, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61cd20266659, moduleTitle=J Vasc Surg ：近端支架联合或不联合远端裸支架治疗主动脉夹层荟萃分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61cd20266659)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939086, encodeId=f1c2193908648, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2020 | 后起之秀：靶向PD-L1的前体治疗药物CX-072, objectType=article, longId=195529, objectId=cb091955294a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb091955294a, replyNumber=0, likeNumber=66, createdTime=2020-10-31, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb091955294a, moduleTitle=ASCO 2020 | 后起之秀：靶向PD-L1的前体治疗药物CX-072, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb091955294a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939035, encodeId=214e19390357c, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=J Vasc Res：CSE会增强巨噬细胞中的OCG并促进动脉瘤的进展, objectType=article, longId=189348, objectId=2a211893488e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a211893488e, replyNumber=0, likeNumber=60, createdTime=2020-09-16, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a211893488e, moduleTitle=J Vasc Res：CSE会增强巨噬细胞中的OCG并促进动脉瘤的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a211893488e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939091, encodeId=ab0b1939091f6, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Circ：Cardiovasc Inte：无症状患者经导管室间隔缺损封堵术后的运动能力和心室重构, objectType=article, longId=196495, objectId=9d8019649570, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d8019649570, replyNumber=0, likeNumber=29, createdTime=2021-02-03, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d8019649570, moduleTitle=Circ：Cardiovasc Inte：无症状患者经导管室间隔缺损封堵术后的运动能力和心室重构, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d8019649570)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939017, encodeId=5b03193901eca, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2020年度胃肠道癌专题讨论会：SBP-101的I期临床数据, objectType=article, longId=186734, objectId=0fc9186e3483, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0fc9186e3483, replyNumber=0, likeNumber=64, createdTime=2020-06-09, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fc9186e3483, moduleTitle=ASCO 2020年度胃肠道癌专题讨论会：SBP-101的I期临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0fc9186e3483)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939027, encodeId=a2c2193902e2a, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=2020年ASCO-SITC：中性粒细胞与淋巴细胞的比例可预测晚期NSCLC患者接受免疫治疗的存活率, objectType=article, longId=187767, objectId=e71318e76739, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e71318e76739, replyNumber=0, likeNumber=74, createdTime=2020-08-28, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e71318e76739, moduleTitle=2020年ASCO-SITC：中性粒细胞与淋巴细胞的比例可预测晚期NSCLC患者接受免疫治疗的存活率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e71318e76739)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939036, encodeId=b9071939036d5, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=J Vasc Res：地高辛减弱巨噬细胞中NF-κB配体诱导的破骨细胞生成的受体活化, objectType=article, longId=189355, objectId=484f18935514, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=484f18935514, replyNumber=0, likeNumber=58, createdTime=2021-01-24, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=484f18935514, moduleTitle=J Vasc Res：地高辛减弱巨噬细胞中NF-κB配体诱导的破骨细胞生成的受体活化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=484f18935514)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939052, encodeId=8cc319390525f, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2020：PD-1单抗Opdivo、CTLA-4单抗Yervoy联合化疗一线治疗非小细胞肺癌，将死亡风险降低31％, objectType=article, longId=194237, objectId=1da819423ef7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1da819423ef7, replyNumber=0, likeNumber=56, createdTime=2020-09-06, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1da819423ef7, moduleTitle=ASCO 2020：PD-1单抗Opdivo、CTLA-4单抗Yervoy联合化疗一线治疗非小细胞肺癌，将死亡风险降低31％, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1da819423ef7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939043, encodeId=c3661939043a2, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Arterioscler Thromb Vasc Biol：抑制CHK 1（检查点激酶1）可以治疗肺动脉高压, objectType=article, longId=192669, objectId=b7eb19266982, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7eb19266982, replyNumber=0, likeNumber=63, createdTime=2020-08-01, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7eb19266982, moduleTitle=Arterioscler Thromb Vasc Biol：抑制CHK 1（检查点激酶1）可以治疗肺动脉高压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7eb19266982)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939062, encodeId=ef37193906203, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Circ：Cardiovasc Inte：外科和经导管主动脉瓣置换术与药物治疗的相对成本, objectType=article, longId=194686, objectId=017019468623, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=017019468623, replyNumber=0, likeNumber=72, createdTime=2021-04-06, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=017019468623, moduleTitle=Circ：Cardiovasc Inte：外科和经导管主动脉瓣置换术与药物治疗的相对成本, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=017019468623)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939095, encodeId=996e19390953a, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Circ：Cardiovasc Inte：经导管Melody瓣膜与外科肺动脉瓣置换长期结局的比较, objectType=article, longId=198139, objectId=634f19813951, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=634f19813951, replyNumber=0, likeNumber=30, createdTime=2021-03-15, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=634f19813951, moduleTitle=Circ：Cardiovasc Inte：经导管Melody瓣膜与外科肺动脉瓣置换长期结局的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=634f19813951)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939055, encodeId=e3641939055b7, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO肝细胞癌（HCC）相关口头报告速览, objectType=article, longId=194518, objectId=32961945180c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32961945180c, replyNumber=0, likeNumber=59, createdTime=2020-10-24, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32961945180c, moduleTitle=ASCO肝细胞癌（HCC）相关口头报告速览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32961945180c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939046, encodeId=0676193904646, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2020：特瑞普利单抗9项研究成果亮相ASCO大会, objectType=article, longId=193341, objectId=d17819334188, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d17819334188, replyNumber=0, likeNumber=0, createdTime=2021-01-16, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d17819334188, moduleTitle=ASCO 2020：特瑞普利单抗9项研究成果亮相ASCO大会, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d17819334188)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939025, encodeId=28851939025c3, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO指南更新：无驱动基因突变IV期非小细胞肺癌一线治疗！, objectType=article, longId=187760, objectId=800018e7605f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=800018e7605f, replyNumber=0, likeNumber=91, createdTime=2020-07-16, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=800018e7605f, moduleTitle=ASCO指南更新：无驱动基因突变IV期非小细胞肺癌一线治疗！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=800018e7605f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939106, encodeId=48f3193910623, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=J Vasc Surg：20年单中心随访结果，第一代支架腔内修复动脉瘤总体结果, objectType=article, longId=200877, objectId=7aa02008e7de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7aa02008e7de, replyNumber=0, likeNumber=94, createdTime=2021-04-02, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7aa02008e7de, moduleTitle=J Vasc Surg：20年单中心随访结果，第一代支架腔内修复动脉瘤总体结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7aa02008e7de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939012, encodeId=4ca11939012b5, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=2020年ASCO胃肠道癌专题讨论会：多胺类似物SBP-101治疗胰腺癌, objectType=article, longId=185294, objectId=bc1a185294cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc1a185294cd, replyNumber=0, likeNumber=81, createdTime=2020-04-08, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc1a185294cd, moduleTitle=2020年ASCO胃肠道癌专题讨论会：多胺类似物SBP-101治疗胰腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc1a185294cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939039, encodeId=4549193903968, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=BMC Cardiovasc Disord：低三碘甲状腺素综合征和硒缺乏症-晚期心力衰竭患者的价值低估, objectType=article, longId=190427, objectId=d5d319042ec3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5d319042ec3, replyNumber=0, likeNumber=0, createdTime=2020-10-28, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5d319042ec3, moduleTitle=BMC Cardiovasc Disord：低三碘甲状腺素综合征和硒缺乏症-晚期心力衰竭患者的价值低估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5d319042ec3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ASC

2020-05-29

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2020：3年或1年伊马替尼辅助治疗高危胃肠道间质瘤的10年随访结果

2020-09-21

quxin068 (审核中...)

前往app查看评论内容

#ASC#

J Cardiovasc Pharmacol Ther：烟民心梗应用氯吡格雷和他汀获益大！高润霖院士等发表CPACS-3研究

2021-03-12

quxin068 (审核中...)

前往app查看评论内容

#ASC#

BMC Cardiovasc Disord：非甲状腺疾病综合征和肾功能不全的合并进一步增加了急性心肌梗死患者的死亡风险

2020-07-24

quxin068 (审核中...)

前往app查看评论内容

#ASC#

J Vasc Surg ：近端支架联合或不联合远端裸支架治疗主动脉夹层荟萃分析

2020-11-20

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2020 | 后起之秀：靶向PD-L1的前体治疗药物CX-072

2020-10-31

quxin068 (审核中...)

前往app查看评论内容

#ASC#

J Vasc Res：CSE会增强巨噬细胞中的OCG并促进动脉瘤的进展

2020-09-16

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Circ：Cardiovasc Inte：无症状患者经导管室间隔缺损封堵术后的运动能力和心室重构

2021-02-03

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2020年度胃肠道癌专题讨论会：SBP-101的I期临床数据

2020-06-09

quxin068 (审核中...)

前往app查看评论内容

#ASC#

2020年ASCO-SITC：中性粒细胞与淋巴细胞的比例可预测晚期NSCLC患者接受免疫治疗的存活率

2020-08-28

quxin068 (审核中...)

前往app查看评论内容

#ASC#

J Vasc Res：地高辛减弱巨噬细胞中NF-κB配体诱导的破骨细胞生成的受体活化

2021-01-24

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2020：PD-1单抗Opdivo、CTLA-4单抗Yervoy联合化疗一线治疗非小细胞肺癌，将死亡风险降低31％

2020-09-06

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Arterioscler Thromb Vasc Biol：抑制CHK 1（检查点激酶1）可以治疗肺动脉高压

2020-08-01

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Circ：Cardiovasc Inte：外科和经导管主动脉瓣置换术与药物治疗的相对成本

2021-04-06

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Circ：Cardiovasc Inte：经导管Melody瓣膜与外科肺动脉瓣置换长期结局的比较

2021-03-15

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO肝细胞癌（HCC）相关口头报告速览

2020-10-24

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2020：特瑞普利单抗9项研究成果亮相ASCO大会

2021-01-16

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO指南更新：无驱动基因突变IV期非小细胞肺癌一线治疗！

2020-07-16

quxin068 (审核中...)

前往app查看评论内容

#ASC#

J Vasc Surg：20年单中心随访结果，第一代支架腔内修复动脉瘤总体结果

2021-04-02

quxin068 (审核中...)

前往app查看评论内容

#ASC#

2020年ASCO胃肠道癌专题讨论会：多胺类似物SBP-101治疗胰腺癌

2020-04-08

quxin068 (审核中...)

前往app查看评论内容

#ASC#

BMC Cardiovasc Disord：低三碘甲状腺素综合征和硒缺乏症-晚期心力衰竭患者的价值低估

2020-10-28

科室
- - 订阅+
  - 更多科室
工具
服务